ID: ALA100207

Max Phase: Preclinical

Molecular Formula: C14H12BrNO4S

Molecular Weight: 370.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)c1ccc(O)c(C(=O)Nc2ccc(Br)cc2)c1

Standard InChI:  InChI=1S/C14H12BrNO4S/c1-21(19,20)11-6-7-13(17)12(8-11)14(18)16-10-4-2-9(15)3-5-10/h2-8,17H,1H3,(H,16,18)

Standard InChI Key:  LRSHTCZOIAVACU-UHFFFAOYSA-N

Associated Targets(non-human)

Actinomyces viscosus 309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.22Molecular Weight (Monoisotopic): 368.9670AlogP: 2.81#Rotatable Bonds: 3
Polar Surface Area: 83.47Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.05CX Basic pKa: CX LogP: 2.37CX LogD: 1.09
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.87Np Likeness Score: -1.60

References

1. Clark MT, Coburn RA, Evans RT, Genco RJ..  (1986)  5-(Alkylsulfonyl)salicylanilides as potential dental antiplaque agents.,  29  (1): [PMID:3941411] [10.1021/jm00151a004]

Source